Targeted Stimuli-Responsive Carriers for Efficient Delivery of Chemotherapeutic Drugs
Chemotherapeutic agents for treating various cancers show considerable side effects and toxicity. Often cancer relapses after initial response to the chemotherapy. Tumor cells are heterogeneous and have the progenitor stem cells which can renew, causing the relapse of the disease. To overcome drug r...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
North Dakota State University
2017
|
| Online Access: | https://hdl.handle.net/10365/26706 |